Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dexamethasone inhibits trabecular cell retraction

E T O'Brien1, S L Perkins, B C Roberts

  • 1Department of Ophthalmology, Duke University Medical Center, Durham, NC 27710, USA.

Experimental Eye Research
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accuracy of <i>in vivo</i> microCT imaging in assessing the microstructural properties of the mouse tibia subchondral bone.

Frontiers in endocrinology·2023
Same author

Relationships between in vivo dynamic knee joint loading, static alignment and tibial subchondral bone microarchitecture in end-stage knee osteoarthritis.

Osteoarthritis and cartilage·2018
Same author

Phylogeography of Caribbean lizard malaria: tracing the history of vector-borne parasites.

Journal of evolutionary biology·2017
Same author

Joint loading and proximal tibia subchondral trabecular bone microarchitecture differ with walking gait patterns in end-stage knee osteoarthritis.

Osteoarthritis and cartilage·2017
Same author

Next-generation IgVH sequencing CLL-like monoclonal B-cell lymphocytosis reveals frequent oligoclonality and ongoing hypermutation.

Leukemia·2015
Same author

Influence of skin colour on diagnostic accuracy of the jaundice meter JM 103 in newborns.

Archives of disease in childhood. Fetal and neonatal edition·2014

Dexamethasone (Dex) treatment increases cell attachment in eye tissues, making them resistant to agents that enhance aqueous humor outflow. This suggests Dex may alter the eye's drainage pathway by strengthening cell connections.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Pharmacology

Background:

  • Glucocorticosteroids, like dexamethasone (Dex), are known to increase resistance to aqueous humor outflow in the eye.
  • Understanding the cellular mechanisms behind this effect is crucial for managing conditions like glaucoma.

Purpose of the Study:

  • To investigate if dexamethasone (Dex) treatment affects the response of cultured endothelial and trabecular meshwork (TM) cells to agents that typically enhance aqueous humor outflow.
  • To explore whether Dex-induced cellular changes in vitro can model alterations in the eye's outflow pathway.

Main Methods:

  • Cultured calf pulmonary artery endothelial (CPAE) and human/porcine TM cells were treated with dexamethasone (Dex) for 1-9 days.
  • Cells were then exposed to ethacrynic acid (ECA), cytochalasin B, or EGTA, and their monolayer and cytoskeletal integrity (tubulin, F-actin) were assessed via immunofluorescence microscopy.

Related Experiment Videos

  • Dex-treated cells were also subjected to combination experiments with ECA and EGTA.

    • Main Results:

    • Dex-pretreated cells became gradually refractory (over 5-7 days) to ethacrynic acid (ECA) and EGTA, but not cytochalasin B.
    • While microtubule disruption occurred normally after ECA in Dex-treated cells, filamentous actin staining showed reorganization.
    • Dex treatment appeared to strengthen cell-to-cell and cell-to-substrate attachments, potentially by interfering with signaling pathways necessary for cellular retraction.

    Conclusions:

    • Dexamethasone (Dex) treatment in vitro leads to increased cellular attachment in endothelial and trabecular meshwork cells.
    • This enhanced attachment may underlie the increased resistance to aqueous humor outflow observed in vivo.
    • Dex interferes with the cellular mechanisms responsible for coordinated retraction and junctional disruption, impacting the eye's drainage system.